Evaluation of the effect of adding low level laser irradiation to drug therapy in patients affected with burning mouth syndrome: A randomized clinical trial

Phase 3

• Conditions: Burning mouth syndrome.; Other and unspecified lesions of oral mucosa; K13.7

• Registration Number: IRCT20200905048623N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

Patients are diagnosed with burning mouth syndrome.
Patients are systemically healthy.
Patients with normal oral mucosa should be examined clinically.
Patients have a burning sensation daily 4 to 6 months with constant or increased intensity during the day.

Exclusion Criteria

Patients with systemic problems manifested by burning mouth, such as diabetes, severe anemia, vitamin deficiency.
There are contraindications to laser administration such as pregnancy, epilepsy, cancer, chemotherapy.
Patients with severe psychiatric disorders, such as major depression

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The amount of mouth burning is measured by asking the patient using a 0 to 10 graduated ruler. Timepoint: The severity of burning will be measured before the start of treatment and at the end of each week after treatment (first week, second week, third week, fourth week) and the end of the third month. Method of measurement: Patient questions are measured using the Visual Analogue Scale, a scale from 0 to 10.